Shionogi & Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Other-Income-Expense-Net" stands at 45.47 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2023.
Shionogi & Co. Ltd.'s first quarter result of 11.23 Billion JPY for the item "Total Other Income Expense Net" represents a decrease of -33.03 percent compared to it's fourth quarter result of the company's last fiscal year.
Also, Shionogi & Co. Ltd.'s first quarter result of 11.23 Billion JPY for the item "Total Other Income Expense Net" represents an increase of 33.46 percent compared to it's first quarter result of last year.
Looking again at the trailing twelve months series (TTM), Shionogi & Co. Ltd.'s first quarter result of 45.47 Billion JPY for the item "Total Other Income Expense Net" represents an increase of 6.60 percent compared to it's fourth quarter result of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.78 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 18.78 Billion Japanese Yens.
The 3 year change is 6.93 Billion Japanese Yens.
The 5 year change is 20.52 Billion Japanese Yens.
The 10 year change is 17.30 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Other Income Expense Net | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Other Income Expense Net | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Other Income Expense Net | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |